EFPIA Italy: All Big Pharma Value Transfers

With this article we want to make available to everyone our collection of EFPIA reports of the main pharmaceutical industries from 2015 to 2018.

The Disclosure Code (EFPIA - Disclosure Code) requires all companies associated with EFPIA (the European Federation of Pharmaceutical Industries and Associations) or national associations which are themselves members of EFPIA to publish relationships with doctors (HCP - Healthcare Professionals) and their organizations (HCO - Healthcare Oganisations).

The Code is applied in the 33 European countries that are members of EFPIA and also to countries that decide to adopt it voluntarily. The geographical area covered goes from Portugal to Russia, from Turkey to Iceland and from Greece to Scandinavia but only the USA and France provide for the transparency code by law.

What is published in the EFPIA reports?

Each company must indicate the name of the doctors and organizations with which it has maintained valuable relationships with respect to the following topics:

• research and development of new drugs through clinical studies carried out in hospitals, universities and public and private health facilities;
• scientific advice;
• scientific seminars and conferences, offering information and updating;
• support for conferences and ECM (Continuing Medical Education) courses organized by public structures, universities, scientific societies and ECM accredited providers.

The Transfers of Value from 2016 to 2022 exceed 1 billion euros

The first pharmaceutical industries in order of Value Transfers

EFPIA reports (in alphabetical order)*

• AbbVie
• Amfgen
• Angelini
• AstraZeneca
• Bayer
• Dompé
• Celgene
• Gilead Sciences
• GlaxoSmithKline
• LeoFarma
• Lilly
• Merck
• MSD
  
• Novartis
  
• Pfizer
• Sanofi
• Teva